Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review

doi:10.5306/wjco.v11.i11.959

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6487)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

433

WORD

143

HTML

3780

Figures (1-4)

383

Tables (1-1)

436

Sum=5175

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

604

Download

708

Sum=1312

Nov 24, 2020 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Nov 24, 2020; 11(11): 959-967
Published online Nov 24, 2020. doi: 10.5306/wjco.v11.i11.959

Full Size Figure Download Figure

Figure 2 Trend in carcinoembryonic antigen levels during irinotecan with oxaliplatin rechallenge therapy. CEA: Carcinoembryonic antigen; IROX: Irinotecan with oxaliplatin.

Citation: Reddy TP, Khan U, Burns EA, Abdelrahim M. Chemotherapy rechallenge in metastatic colon cancer: A case report and literature review . World J Clin Oncol 2020; 11(11): 959-967
URL: https://www.wjgnet.com/2218-4333/full/v11/i11/959.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i11.959